Conditions: Acne
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 70
Healthy volunteers: no

Brief summary:
Exploratory, multi-center, randomised, investigator-blinded, vehicle controlled study using intra-individual comparison involving subjects with acne vulgaris on face to evaluate the efficacy of CD5024 1% cream over a 6-week treatment period compared to its vehicle.

Detailed description:
Study drugs application will be performed once daily, 5 days a week during 6 weeks

Arms:
arm 1: Active drug; arm 2: Placebo of active drug; arm 3: Positive control; arm 4: Placebo of positive control;

Interventions: intervention 1: CD5024 1% cream intervention 2: CD5024 cream placebo intervention 3: CD0271/CD1579 gel intervention 4: CD0271/CD1579 gel placebo
Intervention descriptions: intervention 1: 500 µL on half-face, five days a week during 6 weeks intervention 2: 500 µL on half-face, five days a week during 6 weeks intervention 3: 500 µL on half-face, five days a week during 6 weeks intervention 4: 500 µL on half-face, five days a week during 6 weeks

Protocol document: